Evidence map›Paper›PMID 36771203›Full record

SynthesisNutrients2023

Vitamin D and Sjögren's Disease: Revealing the Connections-A Systematic Review and Meta-Analysis.

Mislav Radić, Ela Kolak, Hana Đogaš, Andrea Gelemanović, Dora Bučan Nenadić, Marijana Vučković, Josipa Radić

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mislav RadićInternal Medicine Department, Rheumatology, Allergology, and Clinical Immunology Division, University Hospital of Split, 21000 Split, Croatia.ORCID 0000-0003-0350-6800
Ela KolakNutrition and Dietetics Department, University Hospital of Split, 21000 Split, Croatia.ORCID 0000-0003-2012-9963
Hana ĐogašInternal Medicine Department, Nephrology and Haemodialysis Division, University Hospital of Split, 21000 Split, Croatia.ORCID 0000-0002-2188-0006
Andrea GelemanovićMediterranean Institute for Life Sciences (MedILS), 21000 Split, Croatia.ORCID 0000-0001-9195-646X
Dora Bučan NenadićNutrition and Dietetics Department, University Hospital of Split, 21000 Split, Croatia.ORCID 0000-0002-2589-2266
Marijana VučkovićInternal Medicine Department, Nephrology and Haemodialysis Division, University Hospital of Split, 21000 Split, Croatia.
Josipa RadićDepartment of Internal Medicine, School of Medicine, University of Split, 21000 Split, Croatia.ORCID 0000-0003-2645-7597

Funding

"Digitalization and improvement of nutritional care for patients with chronic diseases" co-financed by the European Regional Development Fund through the Operational Program, "Competitiveness and Cohesion 2014-2020" KK.01.1.1.04.0115.
6 · The paper itself

Abstract

backgroundThe aim of the present review was to summarize the current evidence about the impact of vitamin D deficiency on pathology and clinical manifestations of Sjögren's disease (SD).

methodsDatabases PubMed, Web of Science, Scopus, and Cochrane library were searched for studies assessing the levels of vitamin D in SD patients using the following keywords: (vitamin D OR calciferol OR cholecalciferol OR 25-hydroxyvitamin D OR 25-hydroxycholecalciferol OR calcidiol OR calcitriol OR 1,25-dihydroxycholecalciferol) AND (Sjögren's Syndrome OR Sjögren's disease) accessed on 20 September 2022. Out of 248 retrieved studies, following the systematic review methodology and defined inclusion and exclusion criteria, 9 clinical studies were eligible to be included in the present review: 4 of them case-control, 4 cross-sectional, and 1 cohort study.

resultsNine studies totaling 670 SD patients and 857 healthy controls were eligible for meta-analysis with moderate to high methodological quality as determined by the Newcastle-Ottawa Quality Scale (NOS). According to the obtained results, a high prevalence of hypovitaminosis D was observed in SD patients when compared to healthy controls (95% CI -10.43, -2.39;

conclusionAvailable evidence points to lower levels of vitamin D in patients with SD in comparison to healthy controls. However, further studies are necessary to understand the underlying mechanisms associated with the role of vitamin D in the development and disease severity of SD.

Indexed as

Sjogren's SyndromeVitamin D DeficiencyCalcifediolCohort StudiesCross-Sectional StudiesHumansVitamin DVitaminsCalcifediolVitamin DVitaminscholecalciferolmeta-analysisSjögren’s diseaseSjögren’s syndromesystematic reviewvitamin D

Identifiers

PMID36771203
PMCPMC9920259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.